Peramivir 200 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 200 mg
Reference Brands: Rapivab (USA)
Category: Anti Viral
Peramivir is a Anti Viral product available as Injection in strengths 200 mg. It corresponds to the reference brand Rapivab (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Peramivir is an antiviral medication used for the treatment of influenza and is marketed under the trade name Rapivab. It was developed by BioCryst Pharmaceuticals and belongs to the neuraminidase inhibitor class of antiviral agents. Peramivir works by acting as a transition-state analogue inhibitor of the influenza neuraminidase enzyme, which plays a key role in the release of newly formed viral particles from infected host cells. By blocking this enzyme, peramivir limits viral replication and helps reduce the spread of the virus within the respiratory tract.
Unlike other neuraminidase inhibitors that are administered orally or by inhalation, peramivir is approved exclusively for intravenous administration. This route of delivery makes it particularly valuable for hospitalized patients, critically ill individuals, or patients who are unable to take oral medications. Peramivir is primarily indicated for the treatment of acute uncomplicated influenza caused by influenza A and B viruses.
The intravenous formulation allows for rapid achievement of therapeutic drug levels and provides a reliable treatment option in clinical settings requiring immediate antiviral intervention. Peramivir is generally used as a single-dose or short-course therapy under medical supervision, especially during seasonal influenza outbreaks or in severe cases requiring inpatient care.
Peramivir — third party manufacturing & bulk supply
Peramivir 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Peramivir is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Peramivir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Peramivir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Peramivir is used for the treatment of acute uncomplicated influenza A and B infections in adults and pediatric patients, particularly when intravenous therapy is required.
Peramivir is a synthetically manufactured neuraminidase inhibitor designed to block influenza virus replication.
The trade name of peramivir is Rapivab (USA) and Rapilacta/Rapiacta in Japan and selected markets.
Rapivab was developed by BioCryst Pharmaceuticals and is marketed in the USA by licensed pharmaceutical partners.
The generic name of Peramivir is peramivir.
The brand name of Peramivir is Rapivab.
Peramivir injection is manufactured by GMP-compliant pharmaceutical facilities, with production locations varying by brand owner and supplying region.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View DetailsLenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers